Menu
PME Symposia
PME Breakfast Symposium (Non-CME)
Friday, August 18 | 8:00 AM – 9:00 AM
Take Action Against Obesity: Do More Than Lifestyle Modifications
Sponsored by Novo Nordisk.
Speaker:
Pamela R. Rama, MD, FACC
Cardiologist
Baptist Heart Specialist
Jacksonville Beach, FL
Program Description:
Establish the urgency to understand that obesity is a disease that needs to be treated like other chronic, progressive diseases. Discuss the underlying physiology that leads to weight regain after weight loss with lifestyle changes alone. Review recommendations from national medical societies on the appropriate use of anti-obesity medication. Discuss data from select trials that evaluated a GLP-1 RA as a chronic weight-management therapy in patients with overweight and obesity. Review dosing and administration information and prescribing tips.
PME Lunch Symposium (Non-CME)
Friday, August 18 | 12:00 PM – 1:00 PM
Explore a Treatment Option for NYHA Class II–III Obstructive Hypertrophic Cardiomyopathy
Sponsored by Bristol Myers Squibb.
Speaker:
Jorge Silva Enciso, MD, FACC
Associate Clinical Professor of Medicine
Director, Hypertrophic Cardiomyopathy Program
Heart Failure, Mechanical Circulatory Support and Transplant Cardiology
UC San Diego Cardiovascular Medicine
San Diego, CA
Program Description:
Redefining the Treatment Landscape for Symptomatic NYHA Class II–III Obstructive Hypertrophic Cardiomyopathy With the First and Only FDA-Approved Cardiac Myosin Inhibitor.
PME Breakfast Symposium (Non-CME)
Saturday, August 19 | 8:00 AM – 9:00 AM
Harnessing SGLT Inhibition in Heart Failure
Sponsored by Lexicon Pharmaceuticals.
Speaker:
Matthew Budoff, MD
Professor of Medicine, UCLA
Endowed Chair of Preventive Cardiology
Lundquist Institute for Biomedical Innovation at Harbor-UCLA
Speaker:
Pam R. Taub MD, FACC, FASPC
Founder and Director of Step Family
Cardiac Rehabilitation and Wellness Center
Professor of Medicine
UC San Diego Health System
Program Description:
Revisit the continuing burden of HF and review the evolution of heart failure guidelines. Underscore the importance of initiating SGLTis upon stabilization and prior to hospital discharge in patients with heart failure transitioning to outpatient care. Explore the clinical features and benefits of newly approved INPEFA™, an inhibitor of SGLT2 and SGLT1, through an overview of its pivotal studies, SOLOIST-WHF and SCORED.
Learning Objectives:
Understand the:
- Continuing burden of and unmet needs in heart failure
- Impact and importance of early, inpatient initiation of GDMT, with SGLTis being a cornerstone therapy, in patients with heart failure
- Outcomes of the INPEFA™ pivotal studies: SOLOIST-WHF and SCORED
- Clinical opportunities for newly approved, INPEFA™ in hospitalized patients transitioning to outpatient care
PME Lunch Symposium (Non-CME)
Saturday, August 19 | 12:00 PM – 1:00 PM
Hear Your Heart: Engaging Black and Latina Women on the Risks of Heart Failure
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc and Lilly USA, LLC.
Speaker:
Matthew Budoff, MD
Professor of Medicine, UCLA
Endowed Chair of Preventive Cardiology
Lundquist Institute for Biomedical Innovation at Harbor-UCLA
Speaker:
Martha Gulati, MD, FACC, FAHA, FASPC, FESC
President, American Society for Preventive Cardiology
Professor of Cardiology, Cedars-Sinai Heart Institute
Anita Friedman Endowed Chair in Women’s Cardiovascular Medicine & Research
Director, Preventive Cardiology
Associate Director, Barbra Streisand Women’s Heart Center
Los Angeles, CA
Speaker:
Pam R. Taub MD, FACC, FASPC
Founder and Director of Step Family
Cardiac Rehabilitation and Wellness Center
Professor of Medicine
UC San Diego Health System
Speaker:
Karol Watson, MD, PhD
Professor of Medicine/Cardiology
Co-director, UCLA Program in Preventive Cardiology
Director, UCLA Barbra Streisand Women’s Heart Health Program
David Geffen School of Medicine at UCLA
Los Angeles, CA
Program Description:
Hear Your Heart is an initiative that aims to combat health disparities and inequities in Black and Latina Women with heart failure. This will be a panel presentation for healthcare providers to encourage providers to address these issues by providing comprehensive and personalized care for Black and Latina women with heart failure. Topics discussed will include health risks and treatment challenges specific to Black and Latina women with heart failure, addressing the at-risk Black and Latina population in your community, and strategies to improve patient engagement and outcomes.
